Literature DB >> 3781020

Diagnostic considerations in virilization: iodomethyl-norcholesterol scanning in the localization of androgen secreting tumors.

L Taylor, J W Ayers, M D Gross, E P Peterson, K M Menon.   

Abstract

Accurate localization of the source of androgen hypersecretion is critical to the appropriate surgical or medical management of women with virilization. Seven patients with virilization and hyperandrogenism of various causes were evaluated with the use of sequential studies: testosterone stimulation and suppression tests; computerized tomography (CT); selective venous catheterization; and 131I-iodomethyl-norcholesterol (NP-59) scintigraphy. Comparison of the diagnostic accuracies of these localization studies with the ultimate diagnoses in this group of virilized women showed that: endocrinologic suppression/stimulation studies are of limited value in tumor localization and helpful only in patients with steroidogenic enzyme deficiencies; both selective catheterization and CT scanning may provide spurious localization data; and NP-59 scintigraphy, by depicting both the anatomic localization and functional androgen hypersecretion, may provide the most significant localization data in the evaluation of patients with virilizing syndromes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3781020

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

1.  A premenopausal woman with virilization secondary to an ovarian Leydig cell tumor.

Authors:  André M Faria; Ricardo V Perez; José A M Marcondes; Daniel S Freire; Roberto Blasbalg; José Soares; Kleber Simões; Sylvia A Y Hayashida; Maria A A Pereira
Journal:  Nat Rev Endocrinol       Date:  2011-02-15       Impact factor: 43.330

Review 2.  Selective venous sampling for androgen-producing ovarian pathology.

Authors:  Eric D Levens; Brian W Whitcomb; John M Csokmay; Lynnette K Nieman
Journal:  Clin Endocrinol (Oxf)       Date:  2008-08-21       Impact factor: 3.478

3.  Noninvasive test for the diagnosis of ovarian hormone-secreting-neoplasm in postmenopausal women.

Authors:  Ilan Cohen; Dan Nabriski; Ami Fishman
Journal:  Gynecol Oncol Rep       Date:  2015-06-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.